Conference Coverage

VIDEO: Could noninvasive prenatal testing mean gene profiling for every pregnancy?


 

AT THE PREGNANCY MEETING

References

ATLANTA – The decision of whether to screen a pregnancy for genetic anomalies should not be taken lightly, especially in light of the invasive procedures required. But what if a simple maternal blood test could provide everything we needed to know about a fetus’ genetic health?

At the annual Pregnancy Meeting sponsored by the Society for Maternal-Fetal Medicine, Dr. Ronald J. Wapner of Columbia University, New York, said that time is quickly approaching, and that cell-free fetal DNA testing should – and will – become a routine part of prenatal care.

Watch an interview with Dr. Wapner here.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

msullivan@frontlinemedcom.com

Recommended Reading

NIH announces Zika virus research priorities
MDedge ObGyn
OPPTIMUM Trial: No benefit found for vaginal progesterone in preterm birth prevention
MDedge ObGyn
VIDEO: SMFM panelist addresses Zika virus testing
MDedge ObGyn
CDC’s emergency operations center moves to Level 1 for Zika
MDedge ObGyn
Ocular symptoms accompany microcephaly in Brazilian newborns
MDedge ObGyn
New evidence strengthens link between Zika and microcephaly
MDedge ObGyn
Evidence-based bundles reduced shoulder dystocia rates
MDedge ObGyn
Project aims to improve care in the ‘4th trimester’
MDedge ObGyn
CDC: Zika virus expected to spread through Puerto Rico
MDedge ObGyn
VIDEO: To optimize children’s oral health, take care of moms first
MDedge ObGyn